Momenta Pharmaceuticals, Inc. (MNTA)

[Boing x 2]

funindasun,

I don't think that is going to be enough. Here is the reasoning for education purposes.

"https://www.washingtonpost.com/health/a-severe-shortage-hits-a-drug-used-for-cancer-immune-disorders-epilepsy-causing-cancelled-treatments-and-rationing/2019/11/01/f2be3c4e-e93a-11e9-9c6d-436a0df4f31d_story.html";

The off label usage appears to be growing by leaps and bounds. MNTA is well aware of this.

You are talking about the 47% but what about the amount needed for the rest of the off label IVIG usages?

If they get a higher improved usage in clinical trials, and an FDA approval, they should be in the drivers seat for some time to come.

Not long to find out now.

Boing X 2